Opinion: Benefit balanced against risk in the biomedical arena

By Joe Panetta

President and CEO, BIOCOM

Southern California is home to the most innovative and cutting edge biomedical research and development community in the world. Each year the region’s life science companies, along with research universities and institutes, generate thousands of ideas for potentially life-saving therapies and medical devices.

Hundreds of these potential products eventually move into clinical trials. Many potential therapies, about one in 20, never make it to market because of some type of safety or effectiveness issue. Ultimately, a few dozen will receive the approval of the U.S. Food and Drug Administration to be prescribed to patients around the country. It is a costly and time-consuming challenge, which can take up to 12 years and $1.5 billion.

In deciding what product gets to market, the FDA engages in a process that balances the risks of products versus the benefits. The FDA’s product review process has long been recognized around the world as the “gold standard” for biomedical product regulation.

It is important to understand that no product is 100 percent safe. While it may be tested in thousands of people during clinical trials, once it gets to market and is used by a wider population, new side effects may become evident. Often in those cases, the public questions how the FDA did not see the problems.

Many times reports on these side effects wind up in the media, giving biomedical companies and the FDA a black eye. The public often misses the fact that 99.99 percent of products approved by FDA have no safety issues.

Southern California’s life science community has contributed to increasing the length and quality of life of patients around the world. It is my hope that our community can appreciate all of the effort that goes into the process of developing products, and that we can better understand and accept that benefit is accompanied by risk. We must accept some level of risk if we desire life-saving innovation.

Related posts:

  1. Opinion: One great deal for the people of San Diego
  2. Opinion: There’s value in bringing ‘Big Pharma,’ S.D. biotech industry
  3. Opinion: Las Patronas gift recipient pays it forward
  4. Opinion: Stop using leaf blowers
  5. OPINION: Pet poo can destroy paradise

Short URL: http://www.lajollalight.com/?p=43742

Posted by Staff on Jun 16, 2011. Filed under News, Opinion. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Bottom Buttons 1

Bottom Buttons 2

Bottom Buttons 3

Bottom Buttons 4

Bottom Buttons 5

Bottom Buttons 6

RSS North Coastal News

  • Man pleads guilty in fatal Del Mar hit-and-run case April 17, 2014
    A man who drove drunk and struck a marine biologist in a crosswalk in Del Mar, then fled the scene, pleaded guilty April 16 to gross vehicular manslaughter while intoxicated and a hit-and-run allegation. Christopher ``Chip’’ Stockmeyer, 41, faces between nine and 15 years in prison when he is sentenced June 20 for the March 28 death of Rachel Morrison. […]
  • Del Mar Powerhouse 10U Champions April 17, 2014
    The Del Mar Powerhouse 10U team played two pool play games and two elimination games to go undefeated in the Triple Crown Sports San Diego Open and win the Division 1 Championship. The boys showed great determination and fight to come away victorious in elimination play and battle for the win with a one-run margin of victory for both semi-final and champions […]
  • Canyon Crest girls crack top three at Arcadia, set new school record April 17, 2014
    Several young women runners from Carmel Valley high schools raced well in the Arcadia Invitational on April 11-12 in Los Angeles. Arcadia is considered to be one of the most competitive high school track and field meets in the country, drawing both national and international athletes to compete. […]